From the survival analysis, LINC00536 and ADAMTS9‐AS1 were significantly associated with poor prognosis of breast cancer, but they have not been reported; therefore, they may become new therapeutic targets and prognostic biomarkers for breast cancer. The gene discussed is ADAMTS9; the disease is breast carcinoma.